In this digital era, Vamsi Upputuri, a leading expert in regulatory automation, explores cutting-edge advancements in ...

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

The conundrum of missing data vs. inter-rater variability.

Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...

Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing ...

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a generative AI software leader in clinical trial analytics, announces that it will present new data ...

Successful detection of brain metastases using RAD 101 (18F-Pivalate) in a novel multiparametric imaging methodology (PET-mpMRI) study across 22 ...

A researcher in the IU Luddy School of Informatics, Computing and Engineering in Indianapolis is leading efforts to develop ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

2 new ACLF clinical trials expected to initiate in 1Q25 3 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trial Data of on-going Phase ...